Nascent Biotech Inc.
SEC CIK 1622057 · NBIO · last insider filing 2024-07-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Holden Lowell Thomas | Director · CFO | filed 2014 - 2024 |
| Carrick Sean | Director · Principal Executive Officer | filed 2015 - 2024 |
| Karas Douglas John | Director | filed 2018 - 2024 |
| Price Brandon | Director · Senior VP Business Development | filed 2015 - 2020 |
| Glassy Mark | Director · CEO | filed 2014 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.